治疗高血压的超声波装置在日本获得首次批准。 Recor Medical's ultrasound device for treating hypertension gets its first approval in Japan.

Otsuka医疗装置的子公司Recor Medical在日本获得批准,使用新的超声波装置治疗抗性高血压。 Recor Medical, a subsidiary of Otsuka Medical Devices, has received approval in Japan for its new ultrasound device to treat resistant hypertension. 天堂RDN系统使用超声波能量,通过瞄准肾动脉周围的神经来降低血压。 The Paradise uRDN system uses ultrasound energy to reduce blood pressure by targeting the nerves around the renal arteries. 根据美国和欧洲的成功研究,这是日本首次批准高血压标注装置。 This marks the first approval in Japan for a device indicated for hypertension, based on successful studies in the U.S. and Europe. 该公司计划进行进一步的研究,以监测该装置的有效性和安全性。 The company plans further studies to monitor the device's effectiveness and safety.